Carmat News - ALCAR

Featured1606 Corp. Signs LOI to Be Acquired by Private Group Seeking to Enter the Public Markets and Utilize AI Technologies for Potential Uplisting

CARMAT: Aeson® total artificial heart highlighted as a very promising solution for heart failure patients with pulmonary hypertension in The Journal of Heart and Lung Transplantation

Up to 25% of advanced heart failure patients suffer from pulmonary hypertension Aeson® could potentially become a standard treatment for these...

CARMAT Achieves the Milestone of 100 Implants of Its Aeson® Total Artificial Heart

Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a...

CARMAT : Information relative au nombre total de droits de vote et d’actions composant le capital social

Déclaration au titre de l’article 223-16 du règlement général de l’Autorité des marchés financiers Regulatory News: CARMAT (Paris:ALCAR): Date...

CARMAT Raises a Total of €9.7 Million

Regulatory News: NOT FOR DIRECT OR INDIRECT DISTRIBUTION IN THE UNITED STATES OF AMERICA, SOUTH AFRICA, CANADA, AUSTRALIA OR JAPAN CARMAT...

CARMAT lance une levée de fonds d’un montant d’environ 10 M€ bénéficiant d’engagements de souscription à hauteur de 7 M€

Levée de fonds composée d'une offre réservée à destination d’investisseurs spécialisés et d'une offre au public destinée à des investisseurs...

CARMAT : Agenda financier 2025

Regulatory News: CARMAT (FR0010907956, ALCAR, éligible PEA-PME), concepteur et développeur du cœur artificiel total le plus avancé au monde...

CARMAT Announces Its Participation in Several Scientific and Investor Conferences During the 1st Half of 2025

Regulatory News: CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a...

CARMAT Delivers a Solid FY 2024 with 42 Implants of Its Aeson® Artificial Heart and Anticipates Continued Strong Momentum in 2025

Over 90 patients have received the Aeson® artificial heart since the first implant in 2013, including 42 in 2024. 2024 Sales of €7 million (a...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Carmat (ALCAR)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

ALCAR News

Featured1606 Corp. Signs LOI to Be Acquired by Private Group Seeking to Enter the Public Markets and Utilize AI Technologies for Potential Uplisting

CARMAT: Aeson® total artificial heart highlighted as a very promising solution for heart failure patients with pulmonary hypertension in The Journal of Heart and Lung Transplantation

CARMAT Achieves the Milestone of 100 Implants of Its Aeson® Total Artificial Heart

CARMAT : Information relative au nombre total de droits de vote et d’actions composant le capital social

CARMAT Raises a Total of €9.7 Million

CARMAT lance une levée de fonds d’un montant d’environ 10 M€ bénéficiant d’engagements de souscription à hauteur de 7 M€

CARMAT : Agenda financier 2025

CARMAT Announces Its Participation in Several Scientific and Investor Conferences During the 1st Half of 2025

CARMAT Delivers a Solid FY 2024 with 42 Implants of Its Aeson® Artificial Heart and Anticipates Continued Strong Momentum in 2025

ALCAR Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Carmat (ALCAR) News

Carmat (ALCAR)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

ALCAR News

Featured1606 Corp. Signs LOI to Be Acquired by Private Group Seeking to Enter the Public Markets and Utilize AI Technologies for Potential Uplisting

CARMAT: Aeson® total artificial heart highlighted as a very promising solution for heart failure patients with pulmonary hypertension in The Journal of Heart and Lung Transplantation

CARMAT Achieves the Milestone of 100 Implants of Its Aeson® Total Artificial Heart

CARMAT : Information relative au nombre total de droits de vote et d’actions composant le capital social

CARMAT Raises a Total of €9.7 Million

CARMAT lance une levée de fonds d’un montant d’environ 10 M€ bénéficiant d’engagements de souscription à hauteur de 7 M€

CARMAT : Agenda financier 2025

CARMAT Announces Its Participation in Several Scientific and Investor Conferences During the 1st Half of 2025

CARMAT Delivers a Solid FY 2024 with 42 Implants of Its Aeson® Artificial Heart and Anticipates Continued Strong Momentum in 2025

ALCAR Discussion

Your Recent History

Go Ad-Free